Risk factor
Good trading liquidity
Profitability factor
Undervalued vs peers
About
GC Biopharma Corp. is a pharmaceutical enterprise primarily involved in the production and distribution of various medical products. Its extensive portfolio encompasses specialized treatments for blood-related conditions, non-prescription remedies, general medications, and immunizations, among other therapeutic solutions. The company was established on November 1, 1969, and its principal corporate offices are situated in Yongin, South Korea.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, reasonably priced on P/FCF
Target Price
The average target price of 006280.KS is 203453 and suggests 65% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to